Privia Health Group, which provides a value-based care platform for physicians, raised $449 million by offering 19.5 million shares (86% insider) at $23, the high end of the upwardly revised range of $21 to $23. The company originally filed to offer the same number of shares at $17 to $19, before increasing its range yesterday. At pricing, Privia commands a fully diluted market value of $2.8 billion.
Privia Health Group plans to list on the Nasdaq under the symbol PRVA. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as lead managers on the deal.
